Faecal Calprotectin Testing Market Grows as Non-Invasive IBD Diagnosis Gains Preference
Market Overview The Faecal Calprotectin Testing Market is expanding as clinicians increasingly favor stool-based biomarker testing over invasive endoscopic procedures for distinguishing inflammatory bowel disease from irritable bowel syndrome. Faecal calprotectin, released by neutrophils during intestinal inflammation, offers a reliable, low-cost screening tool that reduces unnecessary...
0 Commenti 0 condivisioni 4 Views 0 Anteprima
BuzzingAbout https://www.buzzingabout.com